All In Biotech

Drug Trial Radar · NCT07179055

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye

Last checked: Nov 19, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Oct 2025

Primary completion

Sep 2026

Study completion Sep 2026

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Sep 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Conditions

  • Dry Eye

Interventions

  • VSJ-110Drug

    ophthalmic solution

  • PlaceboDrug

    ophthalmic solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Corneal StainingTime frame: Measured over an 8-week treatment period

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Newport Beach, California · Recruiting

  • Vanda Investigational Site

    Andover, Massachusetts · Not yet recruiting

  • Vanda Investigational Site

    Shelby, North Carolina · Not yet recruiting

  • Vanda Investigational Site

    Memphis, Tennessee · Recruiting

  • Vanda Investigational Site

    Lynchburg, Virginia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.